{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 462100402
| IUPAC_name = 4-[(2''R'',3''S'')-4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol
| image = Masoprocol.svg
<!--Clinical data-->
| tradename = Actinex
| Drugs.com = {{drugs.com|CONS|masoprocol}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = B
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = <!-- OTC / Rx-only -->
| legal_status =  
| routes_of_administration = [[Topical]]
<!--Pharmacokinetic data-->
| bioavailability = Very low
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 500-38-9
| ATC_prefix = L01
| ATC_suffix = XX10
| ATC_supplemental =  
| PubChem = 71398
| IUPHAR_ligand = 4265
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00179
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 64490
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 7BO8G1BYQU
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 73468
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 313972
<!--Chemical data-->
| C=18 | H=22 | O=4
| molecular_weight = 302.365 g/mol
| smiles = Oc1ccc(cc1O)C[C@H](C)[C@H](C)Cc2ccc(O)c(O)c2
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C18H22O4/c1-11(7-13-3-5-15(19)17(21)9-13)12(2)8-14-4-6-16(20)18(22)10-14/h3-6,9-12,19-22H,7-8H2,1-2H3/t11-,12+
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = HCZKYJDFEPMADG-TXEJJXNPSA-N
}}
'''Masoprocol''' is an [[antineoplastic]] drug used to treat skin growths caused by sun exposure. A form of [[nordihydroguaiaretic acid]] that is taken by mouth is being studied in the treatment of prostate cancer. 

Also called nordihydroguaiaretic acid, NDGA, and actinex.

==Mechanism==
Nordihydroguaiaretic acid is an antioxidant, and it may block certain enzymes needed for tumor growth. 

It is a [[lipoxygenase inhibitor]].<ref>{{cite journal | pmid = 10950827 | volume=279 | issue=3 | title=Masoprocol decreases rat lipolytic activity by decreasing the phosphorylation of HSL |date=September 2000 | journal=Am. J. Physiol. Endocrinol. Metab. | pages=E593â€“600}}</ref>
==References==
{{reflist}}

==External links==
* [http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a601075.html  MedlinePlus Drug Information]
* [http://www.cancer.gov/dictionary?CdrID=523330 Actinex] entry in the public domain NCI Cancer Dictionary


{{Chemotherapeutic agents}}
[[Category:Antineoplastic drugs]]
[[Category:Catechols]]


{{antineoplastic-drug-stub}}